Showing all 11 results
Amantadine Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Immediate-Release Tablet, packed in moisture-resistant Alu-Alu or Alu-PVC blister strips.
Active Ingredient Strength Primary Clinical Function Amantadine Hydrochloride USP/BP 100 mg The Standard Therapeutic Anchor: The globally validated dose for both Parkinsonian motor control and antiviral prophylaxis. Excipients Proprietary Matrix Rapid-Release System: Engineered to ensure a consistent $T_{max}$ (peak concentration) of approx. 2 to 4 hours for reliable daily protection. Darifenacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Prolonged-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute physical stability of the controlled-release polymer.
Active Ingredient Strength Primary Clinical Function Darifenacin Hydrobromide USP/Ph.Eur.
(Equivalent to Darifenacin base)7.5 mg (PR) The Standard Titration & Geriatric Anchor: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients to control OAB symptoms with minimal side effects. Darifenacin Hydrobromide USP/Ph.Eur. 15 mg (PR) The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for patients who require greater symptom relief and have demonstrated high tolerability to the 7.5 mg dose. Excipients Hypromellose (HPMC) / Dibasic Calcium Phosphate / Magnesium Stearate / Polyethylene Glycol / Titanium Dioxide / Premium Polymeric Film Hydrophilic PR Matrix / Diluent / Lubricant / Plasticizer / Opaque Film (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastrointestinal fluids, the tablet hydrates to form a thick, gelatinous outer layer that strictly controls the diffusion of the highly soluble hydrobromide salt over a 24-hour period) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urological dispensing regimens).
Mirabegron Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix ER Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute physical stability of the extended-release polymers.
Active Ingredient Strength Primary Clinical Function Mirabegron Ph.Eur./USP 25 mg (ER) Initiation / Renal Standard: Base therapeutic unit for assessing patient tolerance and for use in patients with severe renal or hepatic impairment. Mirabegron Ph.Eur./USP 50 mg (ER) Global Urology Standard: High-efficacy adult maintenance therapy for maximum suppression of urge urinary incontinence and detrusor overactivity. Excipients Polyethylene Oxide / Hypromellose (HPMC) / Butylated Hydroxytoluene (BHT) / Magnesium Stearate / Premium Opadry Film Swellable ER Polymer / Hydrophilic Matrix Base / Antioxidant / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the active ingredient over 24 hours) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urology dispensing regimens).
Oxybutynin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE desiccant bottles to ensure the absolute chemical stability of the controlled-release hydrogel network.
Active Ingredient Strength Primary Clinical Function Oxybutynin Chloride USP/Ph.Eur. 5 mg (ER) Initiation Standard: Base once-daily titration unit for the gradual introduction of antimuscarinic therapy. Oxybutynin Chloride USP/Ph.Eur. 10 mg / 15 mg (ER) Global Clinical Standard: Advanced maintenance doses for severe, refractory Overactive Bladder and neurogenic detrusor overactivity. Excipients Hypromellose (HPMC) / Lactose Anhydrous / Macrogol (PEG) / Magnesium Stearate / Titanium Dioxide Hydrophilic Polymer Matrix / Diluent / Plasticizer / Premium Film-Coating (Engineered specifically to form a highly viscous external gel barrier upon swallowing, controlling the exact 24-hour drug diffusion rate) *Pack Sizes: Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-compliance 30-day chronic urology dispensing regimens).
Piracetam Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-gauge PVC/PVDC blister strips to ensure the absolute chemical stability of the highly hygroscopic API.
Active Ingredient Strength Primary Clinical Function Piracetam Ph.Eur./USP 400 mg Initiation / Pediatric Standard: Base unit for pediatric dyslexia and mild vertigo management. Piracetam Ph.Eur./USP 800 mg Global Cognitive Standard: Standard adult maintenance dose for age-related cognitive decline and memory impairment. Piracetam Ph.Eur./USP 1200 mg Acute Neurology Standard: Massive-dose unit designed specifically for Cortical Myoclonus and intensive post-stroke rehabilitation protocols to minimize pill burden. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Macrogol (PEG) / Colloidal Silicon Dioxide / Magnesium Stearate High-Density Diluent / Superdisintegrant / Premium Film-Coating (Engineered specifically to compress the massive API load into a smooth, swallowable, moisture-resistant oblong tablet) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, high-volume chronic neurology dispensing where patients may consume 2.4g to 4.8g daily).
Solifenacin Succinate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or High-Density Alu-PVC blister strips to ensure the absolute stability of the low-dose API.
Active Ingredient Strength Primary Clinical Function Solifenacin Succinate USP/Ph.Eur. 5 mg Global Standard: Starting and standard maintenance dose for Overactive Bladder; required maximum dose for patients with hepatic/renal impairment. Solifenacin Succinate USP/Ph.Eur. 10 mg High-Dose Therapy: Maximum adult dose for severe, refractory urinary urgency and frequency. Excipients Lactose Monohydrate / Maize Starch / Hypromellose / Magnesium Stearate / Macrogol Diluent / Binder / Premium Film-Coating (Engineered for immediate gastric dissolution and light protection) Tamsulosin & Dutasteride Capsules
FreeTamsulosin and dutasteride capsules are a combination therapy used to treat moderate to severe symptoms of benign prostatic hyperplasia (BPH). They are most commonly available in a fixed-dose strength of 0.4 mg tamsulosin hydrochloride and 0.5 mg dutasteride.
Tamsulosin & Dutasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant and child-resistant Alu-Alu blister strips to ensure the absolute stability of both the kinetic polymer matrix and the sensitive hormonal API.
Active Ingredient Strength Primary Clinical Function Tamsulosin Hydrochloride USP/Ph.Eur. 0.4 mg (Modified-Release) Continuous 24-hour uro-selective alpha-1A blockade for immediate symptom relief. Dutasteride USP/Ph.Eur. 0.5 mg Dual 5-alpha-reductase inhibition for profound DHT suppression and prostate volume reduction. Excipients Hypromellose (HPMC) / Butylated Hydroxytoluene (BHT) / Microcrystalline Cellulose / Magnesium Stearate SR Polymer matrix for Tamsulosin / Antioxidant stabilizer for solid-state Dutasteride (Engineered for strict segregation) Tamsulosin & Finasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant and child-resistant Alu-Alu blister strips to ensure the absolute stability of both the kinetic polymer matrix and the sensitive hormonal API.
Active Ingredient Strength Primary Clinical Function Tamsulosin Hydrochloride USP/Ph.Eur. 0.4 mg (Modified-Release) Continuous 24-hour uro-selective alpha-1A blockade for immediate symptom relief. Finasteride USP/Ph.Eur. 5 mg Targeted Type II 5-alpha-reductase inhibition for profound DHT suppression and prostate shrinkage. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Sodium Starch Glycolate / Magnesium Stearate SR Polymer matrix for Tamsulosin / Diluent for Finasteride (Engineered for strict kinetic segregation) Tamsulosin Capsules
FreeTamsulosin capsules are selective alpha-blocker medications used to treat symptoms of an enlarged prostate (Benign Prostatic Hyperplasia). They are most commonly available in a 0.4 mg strength as prolonged-release or sustained-release capsules
Tamsulosin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Gel-Matrix Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the hygroscopic polymers.
Active Ingredient Strength Primary Clinical Use Tamsulosin Hydrochloride USP/Ph.Eur. 0.4 mg (Modified-Release Tablet) Premium Global Standard: Target once-daily, food-independent adult dose for BPH. Excipients Macrogol (Polyethylene Glycol) / Magnesium Stearate / Hypromellose / Iron Oxide Advanced Non-Ionic Gel Matrix / Lubricant / Film Coat (Engineered for strict 24-hour continuous diffusion)
